article · The Lancet Microbe

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial

Mirjam Groger
Ghyslain Mombo‐Ngoma
Lia Betty Dimessa Mbadinga
Isabelle Borghini-Fuhrer
Diane Egger‐Adam
Nsengi Ntamabyaliro
Gaston Tona Lutete
Sarah Arbe‐Barnes
Stephan Duparc
Jangsik Shin
Trésor Bodjick Muena Mujobu
Rella Zoleko Manego
Robert M. Miller
Gauthier Kahunu Mesia
Michael Ramharter

202211 citationsOpen accessUniversité de Kinshasa (UNIKIN)

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Research topics

Malaria Research and Control
Trypanosoma species research and implications
Pharmacological Effects and Toxicity Studies

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s2666-5247(22)00092-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.